The release of neutrophil elastase from highly activated neutrophils mediates lung injury in sepsis, including COVID-19 (28), and inhibitors to neutrophil elastase (sivelestat) are protective in inflammatory lung injury (29), and have been proposed to be beneficial in COVID-19-related lung injury (30). This evidence concerns the gene ELANE and COVID-19.